Literature DB >> 8174891

Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells.

M Pinzani1, V Carloni, F Marra, D Riccardi, G Laffi, P Gentilini.   

Abstract

BACKGROUND/AIMS: Platelet-activating factor (PAF) is an important mediator of proinflammatory cell-to-cell interactions with powerful vasoactive properties. We evaluated the biosynthesis of PAF by cultured human fat-storing cells (FSC), liver-specific pericytes involved in the inflammatory and fibrogenic process of liver tissue.
METHODS: PAF synthesis was evaluated by measuring [3H]acetate incorporation under basal conditions and upon stimulation with A23187, thrombin, and lipopolysaccharide. Further analysis of PAF species synthesized by FSC was performed using gas chromatography/mass spectrometry.
RESULTS: All stimuli induced a significant increase of basal PAF synthesis by FSC. Further analysis showed that > 50% of the newly synthesized PAF species was secreted whereas the remaining fraction was cell-associated. PAF species produced by FSC were able to induce aggregation of rabbit washed platelets with an effectiveness correspondent to 10(-9) mol/L authentic PAF. Gas chromatography/mass spectrometry analysis revealed that a large percentage (74%) of PAF-like lipids synthesized by FSC consisted of 1O-acyl PAF. Finally, stimulation of FSC with PAF caused an increase in cytosolic free calcium, thus suggesting a possible involvement of this pericyte in the well-known effects of PAF on portal pressure.
CONCLUSIONS: These results expand the available knowledge concerning the role of PAF in conditions characterized by extensive activation and damage of the liver sinusoidal endothelium and decreased hepatic scavenger activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174891     DOI: 10.1016/0016-5085(94)90023-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.

Authors:  F Marra; R DeFranco; C Grappone; S Milani; S Pastacaldi; M Pinzani; R G Romanelli; G Laffi; P Gentilini
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 2.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

3.  Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair.

Authors:  T Knittel; C Dinter; D Kobold; K Neubauer; M Mehde; S Eichhorst; G Ramadori
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

4.  Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human liver and in cultured human liver myofibroblasts. Cloning of new isoforms of LIF mRNA.

Authors:  Toru Hisaka; Alexis Desmoulière; Jean-Luc Taupin; Sophie Daburon; Véronique Neaud; Nathalie Senant; Jean-Frédéric Blanc; Jean-François Moreau; Jean Rosenbaum
Journal:  Comp Hepatol       Date:  2004-11-26

5.  Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology.

Authors:  Rada Teodora Sufleţel; Carmen Stanca Melincovici; Bogdan Alexandru Gheban; Zaharie Toader; Carmen Mihaela Mihu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

Review 6.  Immune interactions in hepatic fibrosis.

Authors:  Andrew P Holt; Mike Salmon; Christopher D Buckley; David H Adams
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.